Patents by Inventor Ann Avron

Ann Avron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
    Patent number: 7576177
    Abstract: According to the present invention it is now disclosed that exposure of antigen presenting cells, particularly dendritic cells, to peptides or peptide analogs derived from heat shock proteins will subsequently activate T cells to produce immunomodulatory cytokines and will directly influence the cytokines, chemokines, and surface antigens produced by the exposed antigen presenting cells. The present invention relates to peptides and peptide analogs of heat shock proteins capable of interacting directly with dendritic cells. The present invention further relates to pharmaceutical compositions that include dendritic cells exposed to such peptides and analogs, useful for prevention or treatment of either inflammatory disorders and autoimmune diseases or malignancies, viral infections and allergy.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: August 18, 2009
    Assignee: Andromeda Biotech Ltd.
    Inventors: Yoram Karmon, Ann Avron, Dana Elias
  • Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
    Publication number: 20050163746
    Abstract: According to the present invention it is now disclosed that exposure of antigen presenting cells, particularly dendritic cells, to peptides or peptide analogs derived from heat shock proteins will subsequently activate T cells to produce immunomodulatory cytokines and will directly influence the cytokines, chemokines, and surface antigens produced by the exposed antigen presenting cells. The present invention relates to peptides and peptide analogs of heat shock proteins capable of interacting directly with dendritic cells. The present invention further relates to pharmaceutical compositions that include dendritic cells exposed to such peptides and analogs, useful for prevention or treatment of either inflammatory disorders and autoimmune diseases or malignancies, viral infections and allergy.
    Type: Application
    Filed: July 30, 2004
    Publication date: July 28, 2005
    Inventors: Yoram Karmon, Ann Avron, Dana Elias